PM reviews vaccine development, manufacturing at 3 facilities

Ahmedabad/Hyderabad/Pune, Nov 28: Prime Minister Narendra Modi on Saturday visited Ahmedabad, Hyderabad and Pune to review the development and manufacturing process of coronavirus vaccines at facilities in these cities.
He visited the Zydus Biotech Park in Ahmedabad, Bharat Biotech in Hyderabad and Serum Institute of India in Pune. “The scientists expressed joy that the Prime Minister met them face to face in order to boost their morale and help accelerate their efforts at this critical juncture in the vaccine development journey,” an official statement said.
“The Prime Minister expressed pride in the fact that Indias indigenous vaccine development has progressed at such a rapid pace so far. He spoke on how India is following sound principles of science in the entire journey of vaccine development, while also asking for suggestions to make the vaccine distribution process better,” it said.
The statement said Modi stressed that India considers vaccines as not only vital to good health but also as a global good, and it is Indias duty to assist other countries, including the nations in our neighbourhood, in the collective fight against the virus.
“He (Modi) asked the scientists to express their free and frank opinion on how the country could further improve its regulatory process. The scientists also presented an overview of how they are also developing various new and repurposed drugs to better fight COVID-19,” it said.
Modi began by visiting pharma major Zydus Cadila’s manufacturing facility near Ahmedabad. Wearing a PPE kit, he reviewed the vaccine development process at the company’s research centre, located over 20 km from Ahmedabad. Modi was extensively briefed about the vaccine work at the plant by the company officials. He was briefed about the vaccine production procedure. He interacted with scientists and vaccine developers, an official said.
“Visited the Zydus Biotech Park in Ahmedabad to know more about the indigenous DNA based vaccine being developed by Zydus Cadila. I compliment the team behind this effort for their work. Government of India is actively working with them to support them in this journey,” Modi tweeted after the visit.
Zydus Cadila chairman Pankaj Patel recently said the company is
aiming to complete the vaccine trial by March 2021, and could produce up to 100 million doses a year. Modi, who landed at Ahmedabad at 9.10 am, spent over an hour at the plant, before leaving for the airport, from where he left for Hyderabad at 11.40 am.
Modi landed at Hakimpet Air Force station near Hyderabad around 1 pm and proceeded to pharma major Bharat Biotech’s vaccine manufacturing facility at Genome valley, located around 20 km from the air station, by road. At the facility, he reviewed the progress of Covaxin, a vaccine candidate being developed by the company. He also interacted with Bharat Biotech Chairman and Managing Director Krishna Ella, scientists and senior management. “At the Bharat Biotech facility in Hyderabad, was briefed about their indigenous COVID-19 vaccine.
Congratulated the scientists for their progress in the trials so far. Their team is closely working with ICMR to facilitate speedy progress,” Modi tweeted after his hour-long visit there. (PTI)

Get real time updates directly on your device, subscribe now.

Comments are closed.